Have you read these stories?

India's biggest carmaker gets FOMO after quitting diesel

Maruti feels it would miss out on a sizeable market share if it leaves the space but its rivals stay put.

Srikakulam district

Dec 13, 2019, 11.14 AM IST



Documents potentially misleading in Aurobindo Pharma's Unit-VII: USFDA

The FDA conducted a cGMP (Current Good Manufacturing Practices) inspection at the Unit 7 manufacturing facility from September 19-27 this year.

USFDA issues warning letter to Lantech Pharma for manufacturing violations at Andhra plant

In a warning letter issued to the company's Managi...

FDA pulls up Aurobindo Pharma for 'repeated' failures in CGMP

The FDA recently issued a letter warning the drug- makers unit X1 in Srikakulam...

ET Prime Distribution
Load More...

Other useful Links

Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service